journal article·2024-01Open access

The Interaction between Collagen 1 and High Mannose Type CD133 Up‐Regulates Glutamine Transporter SLC1A5 to Promote the Tumorigenesis of Glioblastoma Stem Cells

Yuanyan Wei, Shuting Geng, Yu Si, Yuerong Yang, Qihang Chen, Sijing Huang, Xiaoning Chen, Wenlong Xu, Yinchao Liu, Jianhai Jiang

Advanced Science· Volume 11· Issue 3

Abstract

Abstract Targeting the niche components surrounding glioblastoma stem cells (GSCs) helps to develop more effective glioblastoma treatments. However, the mechanisms underlying the crosstalk between GSCs and microenvironment remain largely unknown. Clarifying the extracellular molecules binding to GSCs marker CD133 helps to elucidate the mechanism of the communication between GSCs and the microenvironment. Here, it is found that the extracellular domain of high mannose type CD133 physically interacts with Collagen 1 (COL1) in GSCs. COL1, mainly secreted by cancer‐associated fibroblasts, is a niche component for GSCs. COL1 enhances the interaction between CD133 and p85 and activates Akt phosphorylation. Activation of Akt pathway increases transcription factor ATF4 protein level, subsequently enhances SLC1A5‐dependent glutamine uptake and glutathione synthesis. The inhibition of CD133‐COL1 interaction or down‐regulation of SLC1A5 reduces COL1‐accelerated GSCs self‐renewal and tumorigenesis. Analysis of glioma samples reveals that the level of COL1 is correlated with histopathological grade of glioma and the expression of SLC1A5. Collectively, COL1, a niche component for GSCs, enhances the tumorigenesis of GSCs partially through CD133‐Akt‐SLC1A5 signaling axis, providing a new mechanism underlying the cross‐talk between GSCs and extracellular matrix (ECM) microenvironment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer Cells and Metastasis · Glioma Diagnosis and Treatment · Cancer, Hypoxia, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

NHC Key Laboratory of Glycoconjuates Research Department of Biochemistry and Molecular Biology School of Basic Medical Sciences Fudan University Shanghai 200032 P. R. China

Division of Neurosurgery Zhongshan Hospital Fudan University Shanghai 200032 P. R. China

Department of Neurosurgery Provincial Hospital Affiliated to Shandong First Medical University Jinan Shandong 250021 P. R. China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Shanghai Municipality

References (84)

Show source-provided references
1. 10.1101/gad.89160110.1101/gad.891601 ↗
2. 10.1038/nature0738510.1038/nature07385 ↗
3. 10.1101/gad.261982.11510.1101/gad.261982.115 ↗
4. 10.1016/j.trecan.2020.01.00910.1016/j.trecan.2020.01.009 ↗
5. 10.1038/nature0312810.1038/nature03128 ↗
6. 10.1016/j.ccr.2006.11.02010.1016/j.ccr.2006.11.020 ↗
7. 10.1016/j.stem.2018.03.01110.1016/j.stem.2018.03.011 ↗
8. 10.1016/j.stem.2015.02.01510.1016/j.stem.2015.02.015 ↗
9. 10.1038/s41392-020-0110-510.1038/s41392-020-0110-5 ↗
10. 10.1007/978-1-4614-5894-4_110.1007/978-1-4614-5894-4_1 ↗
11. 10.1002/path.228310.1002/path.2283 ↗
12. 10.1016/j.celrep.2012.09.01610.1016/j.celrep.2012.09.016 ↗
13. 10.1073/pnas.121700211010.1073/pnas.1217002110 ↗
14. 10.1016/j.canlet.2016.12.02310.1016/j.canlet.2016.12.023 ↗
15. 10.1002/advs.20220221610.1002/advs.202202216 ↗
16. 10.1111/tra.1261810.1111/tra.12618 ↗
17. 10.1007/s11060-013-1234-z10.1007/s11060-013-1234-z ↗
18. Jiang S. · Hepatogastroenterology · 2014 · 61 · 574
19. 10.1186/1756-9966-31-7110.1186/1756-9966-31-71 ↗
20. 10.1038/modpathol.2011.17010.1038/modpathol.2011.170 ↗
21. 10.3390/jcm901006810.3390/jcm9010068 ↗
22. 10.1016/j.jconrel.2015.03.00810.1016/j.jconrel.2015.03.008 ↗
23. 10.1016/j.stem.2020.04.00810.1016/j.stem.2020.04.008 ↗
24. 10.1186/s40169-018-0198-110.1186/s40169-018-0198-1 ↗
25. 10.18632/oncotarget.411510.18632/oncotarget.4115 ↗
26. 10.1038/nrmicro108710.1038/nrmicro1087 ↗
27. 10.3390/ijms2306321410.3390/ijms23063214 ↗
28. 10.1002/emmm.20120137910.1002/emmm.201201379 ↗
29. 10.1038/nrc224610.1038/nrc2246 ↗
30. 10.1158/1541-7786.MCR-15-030710.1158/1541-7786.MCR-15-0307 ↗
31. 10.1016/j.ccr.2009.03.01810.1016/j.ccr.2009.03.018 ↗
32. 10.1016/j.ccr.2009.02.01110.1016/j.ccr.2009.02.011 ↗
33. 10.1038/nature0537210.1038/nature05372 ↗
34. 10.1016/j.canlet.2009.01.01310.1016/j.canlet.2009.01.013 ↗
35. 10.1016/j.febslet.2007.03.06510.1016/j.febslet.2007.03.065 ↗
36. 10.1038/s41568-019-0216-710.1038/s41568-019-0216-7 ↗
37. 10.1186/s12943-018-0803-310.1186/s12943-018-0803-3 ↗
38. 10.1158/1078-0432.CCR-08-012510.1158/1078-0432.CCR-08-0125 ↗
39. 10.1146/annurev-med-062913-05134310.1146/annurev-med-062913-051343 ↗
40. 10.1016/j.bbamcr.2011.03.01310.1016/j.bbamcr.2011.03.013 ↗
41. 10.1038/s41591-019-0423-510.1038/s41591-019-0423-5 ↗
42. 10.1016/j.cmet.2019.11.02010.1016/j.cmet.2019.11.020 ↗
43. 10.1038/s41467-017-02444-w10.1038/s41467-017-02444-w ↗
44. 10.1053/j.gastro.2018.11.03310.1053/j.gastro.2018.11.033 ↗
45. 10.1002/path.442910.1002/path.4429 ↗
46. 10.1074/jbc.M115.70053410.1074/jbc.M115.700534 ↗
47. 10.1038/s42255-019-0039-610.1038/s42255-019-0039-6 ↗
48. 10.1016/j.canlet.2021.02.02010.1016/j.canlet.2021.02.020 ↗
49. 10.7150/jca.1846610.7150/jca.18466 ↗
50. 10.1007/978-1-4614-5894-4_610.1007/978-1-4614-5894-4_6 ↗
51. 10.1016/j.febslet.2010.01.05010.1016/j.febslet.2010.01.050 ↗
52. 10.1159/00011284710.1159/000112847 ↗
53. 10.3389/fcell.2019.0008610.3389/fcell.2019.00086 ↗
54. 10.1074/jbc.M41409120010.1074/jbc.M414091200 ↗
55. 10.1038/s41467-020-18298-810.1038/s41467-020-18298-8 ↗
56. 10.1073/pnas.191195111710.1073/pnas.1911951117 ↗
57. 10.1111/neup.1211710.1111/neup.12117 ↗
58. 10.1038/sj.bjc.660514310.1038/sj.bjc.6605143 ↗
59. 10.1016/S1097-2765(00)80003-910.1016/S1097-2765(00)80003-9 ↗
60. 10.1016/j.bbamcr.2020.11866310.1016/j.bbamcr.2020.118663 ↗
61. 10.3390/ijms2114495610.3390/ijms21144956 ↗
62. 10.1172/JCI6960010.1172/JCI69600 ↗
63. 10.1038/s41556-019-0407-110.1038/s41556-019-0407-1 ↗
64. 10.1182/blood.202101320110.1182/blood.2021013201 ↗
65. 10.1158/1078-0432.CCR-16-310210.1158/1078-0432.CCR-16-3102 ↗
66. Crunkhorn S. · Nat. Rev. Drug Discov. · 2018 · 17 · 316
67. 10.1016/j.ccr.2011.01.03810.1016/j.ccr.2011.01.038 ↗
68. 10.1016/j.cmet.2018.06.00610.1016/j.cmet.2018.06.006 ↗
69. 10.1016/j.molcel.2017.11.02510.1016/j.molcel.2017.11.025 ↗
70. 10.1016/j.redox.2020.10164310.1016/j.redox.2020.101643 ↗
71. 10.1016/j.ebiom.2016.10.01210.1016/j.ebiom.2016.10.012 ↗
72. 10.1186/s12935-021-01982-010.1186/s12935-021-01982-0 ↗
73. 10.1038/s41586-022-05169-z10.1038/s41586-022-05169-z ↗
74. Xia P. · Am. J. Cancer Res. · 2015 · 5 · 1602
75. 10.1016/j.molcel.2012.08.03010.1016/j.molcel.2012.08.030 ↗
76. 10.1186/1476-4598-11-7310.1186/1476-4598-11-73 ↗
77. 10.1016/j.ccell.2017.12.00310.1016/j.ccell.2017.12.003 ↗
78. 10.1016/j.cellsig.2020.10973610.1016/j.cellsig.2020.109736 ↗
79. 10.1038/nn.351010.1038/nn.3510 ↗
80. 10.1093/neuonc/noab21910.1093/neuonc/noab219 ↗
81. 10.1371/journal.pone.005470810.1371/journal.pone.0054708 ↗
82. 10.1172/JCI14708710.1172/JCI147087 ↗
83. 10.1016/j.molcel.2009.09.03410.1016/j.molcel.2009.09.034 ↗
84. 10.1038/s41598-018-22681-310.1038/s41598-018-22681-3 ↗